Company: Array BioPharma
Job title: Associate Director, Companion Diagnostics & Translational Medicine
Brian Tunquist leads the Companion Diagnostics & Translational Medicine group at Array BioPharma Inc., Boulder, Colorado (recently acquired by Pfizer). The group supports all clinical biomarker activities for all Array drugs in clinical development. His group is responsible for biomarker strategies and translational medicine approaches for retrospective and prospective patient stratification and personalized medicine. The group is involved in the full spectrum of biomarker investigation from early Phase 1/2 exploratory biomarkers to Phase 3 companion diagnostic development and regulatory submission. Brian has been at Array BioPharma for over 11 years. Prior to joining Array, Brian was a post-doctoral fellow specializing in cell signaling at Oregon Health Sciences University. Brian Tunquist received his Ph.D. degree in Pharmacology from the University of Colorado Medical School and B.S. degree in Biochemistry from the University of California, Davis.